A lesser-known cannabinoid, called cannabigerol (CBG), is a non-toxic cannabinoid, which means that the THC concentration is very low (generally less than 1%). CBG is the chemical parent of THC and CBD. Cannabis plants produce cannabigerolic acid (CBGA), the precursor of the three main cannabinoid lines: tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA).
Specific enzymes in the plant break down CBGA and transform it into one of the components we know (THC or CBD) using active agents such as light. In most strains, CBGA is immediately converted to THCA or CBDA. Thus, more THC means less CBG and CBD (and vice versa) depending on the process by which these compounds are synthesized.
There are nowadays different ways to obtain a high CBG level in hemp, such as crossing different plant species or the optimal time to harvest it (e. g. a harvest about 5-6 weeks after the beginning of an 8-week flowering cycle).
What are the effects of CBG?
According to the latest studies carried out by scientists, GBC seems to be very promising and offers a wide range of potential applications, for example in the fight against cancer, the treatment of pain, as an antidepressant, etc.